Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that its wholly owned subsidiary, Eye-Net Mobile Ltd., will start a pilot project with a multi-billion-dollar multinational Japanese electronics company to test its Eye-Net™ Protect cellular-based V2X (vehicle-to-everything) accident prevention solution. This is the second pilot project the Company announced this month, following the announcement about a pilot project with a multi-billion-dollar global Japanese technology company to test Eye-Net Mobile's solution.
The pilot project will be used to validate and evaluate the software development kit (SDK) configuration of the Eye-Net solution and its technical specifications. Upon successful evaluation, the Japanese electronics company, which implements hundreds of thousands of units of advanced dashboard cameras (dashcams) every year, may proceed to integrate the Eye-Net solution into its dashcams.
According to recent reports by Grand View Research, the global dashboard camera market size is expected to reach around $7.5 billion by 2027. An estimated 36.1 million dashcams were sold in 2019, more than 10 million of which were advanced dashcams. Advanced dashboard cameras come with parking motion detection, GPS support, and Wi-Fi connectivity. These features, coupled with government regulations and increasing awareness regarding vehicle safety, are expected to drive demand for advanced dashcams in the coming years.
"This second pilot project is a vote of confidence from another Japanese company, that reinforces our market penetration strategy, targeting the smart devices and services market, including dashcams, head-up displays, wearable devices, navigation aids, and IoT platforms,” said Dror Elbaz, COO & Deputy CEO of Eye-Net Mobile. "We decided to focus on the Japanese market, which is often characterized by early adopters of new technologies and innovations, enabling quick market penetration. Concentrating on one geographic region will help us to achieve a critical mass of Eye-Net Protect users in a defined area, thus increasing the chance of preventing accidents and saving lives.”
The Eye-Net Protect V2X solution is designed to protect the most vulnerable road users in real time—including pedestrians, cyclists, scooter drivers and car drivers—by providing collision alerts when the road users have no direct line of sight. An SDK configuration allows Eye-Net Mobile to integrate its solution with leading location-based products such as wearable devices, dashboard cameras, navigation aids, infotainment systems, third-party applications and other smart devices.
For more information about Eye-Net Mobile, please visit www.eyenet-mobile.com, or follow the Company’s LinkedIn page, Eye-Net Mobile; Twitter, @EyeNetMobile1; and Instagram channel, Eyenetmobile1, the contents of which are not incorporated into this press release.
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both "in-line-of-sight” vision systems and "beyond-line-of-sight” cellular-based applications. Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients’ movement.
The company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the Advanced Driver Assistance Systems (ADAS), the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.
For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.foresightauto.com, follow @ForesightAuto1 on Twitter, or join Foresight Automotive on LinkedIn.
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses the pilot project with the Japanese electronics company, that upon successful evaluation, the Japanese electronics company may proceed to integrate the Eye-Net solution into its dashboard cameras, the size of the dashboard camera market, the potential of the company’s products, and the company’s market penetration strategy. Because such statements deal with future events and are based on Foresight’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in Foresight's annual report on Form 20-F filed with the Securities and Exchange Commission ("SEC") on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the contents of third party websites.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200828005121/en/
Call to Freedom, a nonprofit organization focused on navigating a healthy path for victims of human trafficking, has received the 28th annual Monroe E. Trout Premier Cares Award and a $100,000 cash prize from Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company.
Sponsored by Premier and its alliance of more than 4,100 hospitals and health systems and approximately 200,000 other providers and organizations, the Premier Cares Award recognizes exemplary efforts by nonprofit community organizations to improve the health of populations in need.
Call to Freedom (CTF), based in Sioux Falls, South Dakota, provides supportive services for victims of human trafficking including safe housing, mental health counseling, medical assistance, transportation and more. Since CTF’s inception in 2016, the organization has served more than 300 survivors and has secured stable employment for 90 percent of individuals residing in Marissa’s Project, CTF’s supportive housing program, within six months. The nonprofit also works with the community to educate and provide resources on combatting human trafficking.
"When an individual comes out of a human trafficking scenario, we aim to provide protection, healing and restoration of the body, mind and soul,” said Becky Rasmussen, Executive Director of Call to Freedom. "At Call to Freedom, we work as a community bridge to connect these victims and survivors with the resources and services they need, including having a safe space to go and a friendly face to talk to. We are so grateful to Premier for recognizing the incredible work of our frontline providers and honoring our efforts with the Premier Cares Award. These funds will ensure every client has the resources and support they need, while allowing us to educate, train and advocate to reduce human trafficking in South Dakota and the region.”
Medical care is one of the top concerns for survivors of human trafficking. Call to Freedom has collaborated with Avera Health, an integrated health system and Premier member based in Sioux Falls, to establish best practices and protocols for the needs of this population. Working with case managers from both organizations, clinicians in Avera’s emergency departments are able to treat the victims without any questions, guaranteeing confidentiality and an atmosphere of safety during their visits.
"I am incredibly proud of the outstanding organizations across the country that are extending a lifeline to the medically underserved in our communities,” said Susan DeVore, CEO of Premier. "Human trafficking victims often have significant medical concerns, including substance abuse and mental health issues. The partnership Call to Freedom has created with Avera comes from a place of compassion and demonstrates how both organizations are community leaders in providing a safe avenue for this vulnerable population. Call to Freedom and all of its frontline providers are truly making an impact on the members of its Sioux Falls community, and we are thrilled to recognize their efforts.”
A panel of national healthcare leaders selects the Premier Cares Award winner each year. The program spotlights community-based healthcare initiatives and helps other organizations learn to replicate the programs, as well as provides funding support to help winners advance their programs. To date, the program has provided more than $3 million to more than 100 organizations nationwide.
Premier has presented the Cares Award annually since 1991, when it was created by Dr. Monroe E. Trout, former CEO of American Healthcare Systems, one of Premier’s heritage organizations. The competition is open to nonprofit organizations that have been in existence for more than two years, are providing creative solutions to health status improvement, can provide documentation of outcomes and impact on a specific population, and have programs that can be replicated in other communities.
About Call to Freedom
Navigating a healthy path for victims of human trafficking. Call to Freedom provides victim-centered responsive services to those who have experienced sexual exploitation and human trafficking. Our Vision is to create a cohesive community model of care and support for victims, bringing communities together while educating and advocating to stop human trafficking. The focus of Call to Freedom’s work involves responding to victims by creating a strong network of frontline providers who can offer emergency housing, physical and mental health care, medical assistance, chemical dependency treatment, trauma counseling, job skill training, transportation, occupational therapy, and other services as needed. Due to very limited safe housing options, Call to Freedom opened a small supportive housing project named "Marissa’s Project” in October of 2016. Please visit Call to Freedom sites on www.calltofreedom.org, as well as Twitter, Facebook, Instagram, and You Tube.
About Premier Inc.
Premier Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of more than 4,100 U.S. hospitals and health systems and approximately 200,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost. Premier plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, Facebook, LinkedIn, YouTube, Instagram and Premier’s blog for more information about the company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201028005660/en/
VANCOUVER, BC, Oct. 22, 2020 /PRNewswire/ -- Clarius Mobile Health, a pioneer and innovator in high definition medical imaging devices, today announced increased adoption of its Clarius L7 HD handheld ultrasound scanner by interventional pain management specialists for needle-guided injections. Clarius has shipped over 3,300 linear scanners for physicians specifically doing injections and pain management, seeing over 100% quarter-over-quarter growth. The wireless point-of-care device offers quality ultrasound imaging of anatomy under the skin for more accurate and consistent placement of pain medication.
"Pandemic quarantine has worsened the problem of pain disorders, deconditioning and disuse. This has been worst among our most vulnerable patients. Now more than ever, targeting the pain generator with safe and affordable imaging techniques such as ultrasound is preferable with less risk of adverse side effects than exposing the whole body to a drug," suggests Dr. David Rosenblum, Director of Pain Management at Maimonides Medical Center in New York.
According to recent CDC research, an estimated 50 million U.S. adults suffer from chronic pain.
"If injected in the right location, pain medication can provide effective pain relief. Yet, many procedures are still being performed 'blind' by only using landmark identification, often with suboptimal results," warns Clarius CEO Laurent Pelissier. "Ultrasound-guided injections are a recognized best practice to maximize pain relief for adults, but the cost and complexity of cart-based ultrasound have been a barrier to adoption, until recent years. We're now seeing increased adoption of the Clarius L7 HD wireless handheld ultrasound scanner as a convenient solution to remove the guesswork and make patient safety and procedural success both easier and affordable."
In addition to being a highly portable handheld device, Clarius linear scanners are wireless, a design that offers several advantages, allowing for free movement and easy infection control with no cords to clean.
"As a pain management specialist, visualization helps improve accuracy, avoid complications and maximize the chances of my procedures helping the patient," continues Dr. David Rosenblum. "All pain specialists should know that ultrasound no longer means a large expensive tower. My portable Clarius scanner is an invaluable tool that I can easily take from room to room. I'm committed to educating my peers on how they can benefit from this new and affordable technology."
The Pain Management Best Practices Inter-Agency Task Force Report issued in 2019 confirmed "an existing shortage of pain management specialists, leaving a vulnerable population without adequate access to care" and recommended the use of image-guided interventional procedures using ultrasound.
To learn more about ultrasound-guided injections, join the FREE webinar "Bullseye - Why Ultrasound is Now the Standard for Guiding Injections" hosted by Clarius featuring Dr. Rosenblum on Wednesday, October 28th, 2020 at 2PM PT/5PM ET/9 PM GMT/10PM CET. Register here. It's time to close the gap on the number of adults living with pain and access to effective interventional pain management.
About Clarius Mobile Health
Clarius is on a mission is to make accurate, easy-to-use and affordable ultrasound tools available to all medical professionals. Its handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high resolution ultrasound images traditionally only available with bulkier, high end systems. More than 750,000 scans have been performed by 27,000 users since Clarius introduced its first portable scanner in 2016. Clarius scanners are available in more than 50 countries, with the new Clarius HD available now in the United States, Europe, Australia, Hong Kong, Indonesia, Korea with other countries to follow. For more, visit clarius.com.
Genèse CastonguayMarketing Vice President
Clarius Mobile Health350-3605 Gilmore WayBurnaby, BC V5G 4X5Canada
email@example.com | www.clarius.comPhone: +1 (866) 657-9243 ext. 221 | Direct: +1 (604) 260-7077
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarius-handheld-ultrasound-adopted-by-pain-management-physicians-for-improved-accuracy-in-needle-guided-injections-301157973.html
SOURCE Clarius Mobile Health